ALVO
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$5.32
−1.12%Forward multiples
Based on analyst estimates
- P/E forward
- 35.93x
- P/E 2026E
- —
- P/E 2027E
- 23.75x
- P/E 2028E
- 11.23x
- P/S forward
- 2.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -9.91x
- Price / sales
- 3.86x
- Price / cash flow
- -9.55x
Enterprise value
- Enterprise value
- $3.2B
- EV / sales
- 6.52x
- EV / EBITDA
- -2250.74x
- EV / EBIT
- 67.77x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026